There is no established or FDA-approved medication that treats the core symptoms of RAD or DSED. AACAP’s 2016 practice parameter reported that no psychopharmacological intervention trials had been conducted at that time. Since then, one small randomized study has tested intranasal oxytocin in youths with RAD. That study looked at short-term reward processing, not at whether the drug treats the disorder, and it did not establish a medication treatment for RAD.
In short, no current drug targets the attachment difficulty itself, and no medication has been approved by the Food and Drug Administration to treat an attachment disorder. What medication can do, in some children, is treat a separate condition that is sitting alongside the attachment disorder and getting in the way.
That distinction is the whole subject of this page, because it changes what you should expect from a prescription and what questions to ask before your child starts one. It also changes where the real work happens, which is in the caregiving relationship and in attachment disorder treatment built around it.
Is There a Medication for Attachment Disorder?
No, and the guidance on this point is not ambiguous. Two things are worth separating: what the professional guideline actually says, and why the disorders themselves do not present a drug target.
What the Practice Parameter Says
The American Academy of Child and Adolescent Psychiatry addresses this directly in its practice parameter on reactive attachment disorder and disinhibited social engagement disorder. Its recommendation is clear: psychopharmacological interventions are not indicated for the core features of either disorder. The parameter adds that no psychopharmacological intervention trials for these disorders have been conducted. It also states that there are no indications for medication to treat them [1].
Researchers have not established a medication target that produces clinically meaningful improvement in core RAD or DSED symptoms. That is different from saying that no relevant neurobiological mechanisms exist.
What Reactive Attachment Disorder and DSED Actually Are
RAD and DSED are trauma- and stressor-related disorders. Both are associated with severely insufficient care early in life. For RAD, the disturbance must be evident before age five, and the child must have a developmental age of at least nine months. DSED also requires a developmental age of at least nine months, but it does not carry the same DSM-5 rule about onset before age five.
Both are disorders of emotional attachment rather than of temperament, and both are diagnosed from a pattern in the child’s behavior over time rather than from any single incident. Underneath each of them is trust that never had the conditions to form, and building it takes longer than families expect.
In RAD, a child rarely turns to a caregiver to seek comfort or seek affection, shows few positive emotions during ordinary social interaction, and displays a consistent pattern of emotionally withdrawn behavior. In DSED, the pattern runs the other way: indiscriminate friendliness toward unfamiliar adults and a lack of wariness of strangers.
The effects reach past behavior. Emotional regulation is harder, because being soothed by someone else is how a child learns to soothe themselves. Long periods of deprivation can also affect the child’s physical growth and emotional development. Healthy bonds support development in several areas at once, which is why their absence shows up in several areas at once. In a school-aged child, reactive attachment disorder symptoms often look like behavior problems long before anyone connects them to attachment.
How Common Are RAD and DSED?
Both conditions are rarer than the internet suggests. It is worth being precise, because a widely repeated figure of 1 to 2 percent of children circulates without much behind it. The practice parameter reports that RAD is thought to be rare. The single published community study, of 350 Romanian preschool children recruited from pediatric waiting rooms, found no cases at all. Among young children raised in institutional settings for varying periods, the emotionally withdrawn type of RAD was found in 4.1 percent at 54 months. Among children currently living in institutions, as many as 40 percent show significant signs of it.
For DSED, the community point prevalence was 2 percent, rising to 17 to 18 percent among children aged two and a half to four and a half with institutional rearing histories. The parameter notes the condition occurs in fewer than 20 percent of children even in these high-risk populations [1].
The pattern in those numbers is the useful part. These are disorders of circumstance rather than of the general population, and the risk concentrates sharply where early caregiving was absent rather than merely imperfect.
Why No Medication Targets the Attachment Itself
Both attachment disorders are defined by a relationship that did not form, following a history of insufficient care. Reactive attachment disorder shows up as a consistent pattern of emotionally withdrawn behavior toward primary caregivers, and disinhibited social engagement disorder as an indiscriminate approach to unfamiliar adults. Our overview of the signs of an attachment disorder covers how the two present differently.
A medication can change how a child’s nervous system handles fear, attention or mood. It cannot supply the experience of being reliably cared for, which is what meets a child’s basic emotional needs and what the diagnosis is missing. Neither can it teach a child to form meaningful connections; that capacity grows out of repeated experience with a caregiver who stays. This is why the supported treatments are all relational, and why a prescription on its own is not a treatment plan for these conditions.
What Medication Can Treat: The Conditions Alongside It
Here is where the picture opens back up. The same practice parameter states that pharmacological intervention for comorbid disorders, such as related anxiety disorders, ADHD, or mood disorders, may be indicated when a comprehensive assessment demonstrates ongoing symptoms and impairment [1]. Medication is not off the table for a child with an attachment disorder. It is simply aimed at a different diagnosis.
Conditions That Commonly Travel with RAD and DSED
Comorbidity in these children is the norm rather than the exception. The parameter documents depressive symptoms in young children with histories of institutional rearing. It also documents post-traumatic stress disorder co-occurring with both RAD and DSED in maltreated children. High rates of inattention and overactivity follow early social deprivation, and ADHD comorbidity alongside DSED is documented in preschool and school-aged children. In older children and adolescents diagnosed with attachment disorders, the parameter also notes extensive comorbidity, along with intellectual disabilities, language problems and learning difficulties [1].
Two practical consequences follow. First, an accurate diagnosis matters more here than in most of child psychiatry. Attachment disorders share surface features with autism spectrum disorder, oppositional defiant disorder and ADHD, and the treatment implications differ completely. Attachment disorders are classified in the Diagnostic and Statistical Manual alongside other psychiatric disorders, and like most mental disorders, they rarely arrive alone. The mental health conditions that accompany them most often are emotional disorders such as depression and anxiety, together with ADHD and post-traumatic stress disorder.
Second, a child can genuinely have both, and treating the co-occurring condition is not a distraction from the attachment work.
Medication Classes and the Diagnosis Each One Treats
It is worth being precise about what these medications are for, because lists of drug names attached to attachment disorder circulate widely and they mislead. AACAP’s plain-language guidance for families, updated in June 2026, groups psychiatric medications for children by the conditions they treat [2]:
- Stimulants and non-stimulants, including atomoxetine, guanfacine, viloxazine and clonidine, are used for ADHD
- Antidepressants, primarily SSRIs, are used for depression, anxiety disorders, OCD, and PTSD
- Mood stabilizers and anticonvulsants are used for bipolar disorder, severe mood swings, and impulse control problems
- Antipsychotics are used for psychotic symptoms, tics, and severe irritability or agitation
- Anti-anxiety medications other than SSRIs are described as infrequently used in children and may help in certain cases of severe anxiety
A stimulant helps a child who has ADHD, and an SSRI may be appropriate for a child with a diagnosed anxiety disorder or depression when the expected benefits outweigh the risks.
A mood stabilizer is for something like bipolar disorder. None of them is a treatment for an attachment disorder. Which one fits a particular child, or whether any does, is a prescribing decision. A clinician makes it after a diagnostic evaluation, and it is not something to work out from an article.
What the Case Reports Actually Show
Search this topic, and you will run into a 2010 paper reporting improved functioning in children diagnosed with reactive attachment disorder after SSRI therapy. It is worth knowing what it is, because the title promises more than the study delivers.
It is two case studies. The author describes SSRI treatment in two children who had RAD alongside other diagnoses. He reports improvement in mood, behavior, and some attachment behaviors, which he describes as unexpected. Crucially, the paper itself says two things. Pharmacological interventions may have efficacy in treating comorbid conditions. But there is no literature supporting the use of pharmacological treatment to address the core attachment deficit [3].
AACAP found no pharmacological intervention trials when its parameters were published in 2016. Since then, one small randomized experimental study has evaluated intranasal oxytocin in youths with RAD, but it did not test long-term remission of RAD or establish clinical efficacy. There remains no evidence-based medication treatment for the disorder’s core symptoms.
Risk Factors and Why an Accurate Diagnosis Comes First
Attachment disorders follow a documented history of insufficient care, and the risk factors are consistent. They include emotional neglect, child abuse, and repeated changes of caregiver. They also include settings where many caregivers rotate through a child’s life without any one of them becoming a stable figure. Children in foster placements and adopted children who spent early months in institutional care are over-represented for that reason. Even so, most children who face hardship do not develop RAD.
Other Risk Factors to Know
Significant trauma in the household raises the risk, as does parental mental illness or substance abuse that interferes with responsive caregiving at an early age. A caregiver who is unwell and unsupported is not a bad caregiver, which is why parenting skills coaching and support for the adults is treatment rather than blame. Our guidance on how to manage burnout and stress is written for the adult side of that.
Consistent, emotionally responsive caregiving is an important protective factor. Outcomes still vary with the timing, duration, and severity of adversity, and with the child’s later environment and individual needs. Early intervention matters for the same reason: the sooner a stable relationship is in place, the more room the child’s ability to form healthy attachments has to develop.
How a Mental Health Professional Reaches a Diagnosis
To diagnose reactive attachment disorder, a clinician takes the child’s history, observes the child with their caregivers, and judges whether the pattern is consistent and severe enough to meet criteria. A child psychiatrist or another qualified mental health professional looks at the child’s symptoms across settings rather than at a checklist. One criterion is an exclusion: the diagnosis is not made when autism spectrum disorder better explains the presentation. An early diagnosis is worth pursuing where the history raises the question, because the interventions that help work better the sooner the caregiving relationship becomes stable.
This is the step that decides whether medication has any role, because an accurate diagnosis is what identifies the co-occurring conditions, and the signs of co-occurring disorder are worth reading alongside this. Getting it wrong in either direction has consequences. Missed, and a child’s ongoing emotional issues go untreated. Over-applied, and a child ends up medicated for psychiatric disorders they do not have.
Before a Child Starts a Medication
If a clinician does recommend medication for a co-occurring condition, the process matters as much as the choice.
What a Prescriber Should Explain
AACAP’s guidance is that a thorough diagnostic evaluation comes before any recommendation. The clinician should fully explain the reasons for recommending medication, the benefits it is expected to provide, how long it will be taken, possible adverse effects, and the other treatment alternatives. AACAP also states plainly that psychiatric medication should not be used alone. It should be part of a comprehensive plan of treatment, with ongoing medical assessment and, in most cases, individual or family psychotherapy [2].
If a prescription arrives without that conversation, asking for it is reasonable rather than difficult. Our guide to what to expect from psychotherapy and your mental health treatment plan covers what a plan should contain.
The Caution About Young Children
The practice parameter is explicit on one point. There is no data on the short- and long-term effects of these agents on rapidly developing brains, and that gap reinforces the need for a cautious approach, particularly in preschool-aged children [1]. Caution is not a prohibition. It means the threshold for prescribing should be higher the younger the child is, and that ongoing monitoring is part of the deal rather than an optional extra.
Side effects are tracked physically as well as behaviorally, since several classes affect sleep, appetite, growth, and metabolic measures. Our post on how mental health affects your physical health explains why that monitoring is not incidental.
Who Oversees Medication for a Child in Foster Care
Many children with these diagnoses are in foster or adoptive placements, which adds a layer of paperwork that is genuinely useful to know about. Minnesota requires a child’s out-of-home placement plan to name who is responsible for oversight of the child’s prescription medications. It also requires that physicians be consulted and involved in assessing the child’s health and deciding appropriate medical treatment [4].
If you are fostering and are unsure who holds that responsibility for a child in your home, that plan is where the answer is written down. Clear responsibility for medication oversight helps ensure that prescriptions, side effects and continued need are reviewed rather than simply carried forward without reassessment.
The Treatments That Are Actually Supported
The parameter’s affirmative recommendations point in one direction: a child needs an emotionally available attachment figure, and treatment should be built around establishing that relationship. For disinhibited social engagement disorder, it also suggests limiting a child’s contacts with noncaregiving adults, and it supports adjunctive interventions where aggression or oppositional behavior is present [1].
In practice, that means working with the caregivers as much as the child, since both the child and the adults raising them are part of the treatment [1]. Typical components include parent education and parenting skills coaching, behavior management training, family therapy, and trauma-focused therapy where maltreatment is part of the history.
Approaches that coach a caregiver and child together, of which Parent-Child Interaction Therapy is the best known, sit squarely in that category. Therapy sessions that include the caregiver tend to do more for behavioral challenges than sessions with the child alone, because the goal is to build healthy relationships in the home where the child actually lives. Cognitive behavior therapy is often part of the picture for a co-occurring anxiety or mood condition. Our family therapy team works with the caregiving relationship directly, which is where the change has to land.
Interventions to Avoid
This is the most important paragraph on the page. AACAP recommends that clinicians not use interventions meant to enhance attachment that involve noncontingent physical restraint or coercion. That includes therapeutic holding or compression holding, reworking of trauma such as rebirthing therapy, and promotion of regression for reattachment.
These approaches have no empirical support and have been associated with serious harm, including death. Six child deaths have been attributed to their use, and AACAP, the American Psychiatric Association, and the American Professional Society on the Abuse of Children have all issued policy statements opposing coercive therapies for children with serious attachment disturbances [1].
Programs offering these methods still market to desperate parents, and they tend to appear exactly when a family has run out of other options. A provider proposing physical restraint, forced holding, or induced regression as attachment treatment is operating outside accepted practice, whatever the testimonials say. They tend to find families who are exhausted and looking for anything that might work.
Is There a Medication for Anxious Attachment?
A second group of readers arrives here as adults, having found the phrase anxious attachment online and wondering whether a pill exists for it. The short answer is no, and for a different reason than above.
Attachment styles, meaning secure, anxious, avoidant, and disorganized, come from attachment research rather than from the Diagnostic and Statistical Manual. They are not diagnoses, so there is nothing to prescribe for. What can be diagnosed and treated is a co-occurring condition. Anxiety disorders occur alongside anxious attachment often enough that this is a real question, not a technicality. If an anxiety disorder is present, treating it is worthwhile on its own terms.
Treating the anxiety disorder is not the same as changing the attachment pattern, though, and it helps to keep the two goals separate rather than expecting one to deliver the other. What changes the pattern is relational and practical rather than pharmaceutical. Therapy does the structural work, and several of the techniques for managing anxiety help in the meantime because the physical experience overlaps.
Are There Medications That Can Manage Some Symptoms of Attachment Disorder?
There’s no medication that treats attachment disorder itself; healing happens through therapy and consistent, nurturing relationships. However, a psychiatrist may prescribe medications to manage co-occurring symptoms like anxiety, depression, sleep problems, hyperactivity, or explosive anger. These medications work best alongside attachment-focused therapy, not as a replacement. A thorough evaluation helps determine whether medication support is appropriate.
What Happens in Adolescence
Attachment disorders are described as conditions of early childhood, which leaves families wondering why the difficulties are still there at fourteen. Research published in February 2026 speaks to that. A systematic review following PRISMA methodology screened 1,443 records and included eight studies. It found that adverse childhood experiences are associated with a greater presence of RAD symptoms and other mental health problems in adolescents. Adolescents under protective measures who had experienced those adversities showed more RAD-associated symptoms. The authors conclude that these experiences can lead to further development of RAD and its maintenance during adolescence [5].
That is worth holding onto for two reasons. RAD-related symptoms can be present in adolescents with histories of severe childhood adversity, but evidence on long-term persistence, prognosis and treatment response remains limited. Persistence does not necessarily mean treatment failed, but neither should it be described as inevitable or expected for every child.
It also means the adolescent years are often when medication gets raised again, usually because a co-occurring condition has become harder to manage. That is exactly when the distinction this page opens with matters most: the medication is for the co-occurring condition, not for the attachment disorder.
Common Questions About Attachment Disorder Medication
What Is RAD Medicine?
There is no such thing as a RAD medicine in the sense of a drug for the disorder. The phrase usually refers to whatever a child with RAD has been prescribed, which will be a medication for a co-occurring diagnosis such as ADHD, an anxiety disorder, or depression.
Asking a prescriber which diagnosis a given medication is treating is a fair and clarifying question, and the answer should be a specific condition rather than the attachment disorder. If a child is on several medications, asking the same question about each one is how families discover that a prescription added during a crisis two years ago is still running with no one reviewing it.
Can a Child Recover From an Attachment Disorder?
Early identification and treatment improve outcomes, and the mechanism is a stable, emotionally available caregiving relationship rather than a particular technique. What that looks like over years varies with how early the disruption happened, how long it lasted, and what the child’s situation is now.
Recovery is also not the only useful goal. A child who is safer, sleeping, in school, and less frightened of closeness has gained something real whether or not the diagnosis is eventually dropped. Many children reach adulthood able to form healthy attachments after a start that gave them no reason to expect it.
Sources
- Zeanah CH, Chesher T, Boris NW, and the AACAP Committee on Quality Issues. Practice Parameter for the Assessment and Treatment of Children and Adolescents With Reactive Attachment Disorder and Disinhibited Social Engagement Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2016;55(11):990-1003. https://www.jaacap.org/article/S0890-8567(16)31183-2/fulltext
- American Academy of Child and Adolescent Psychiatry. Psychiatric Medication for Children and Adolescents, Part I: How Medications Are Used, and Part II: Types of Medications. Facts for Families, updated June 2026. https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Psychiatric-Medication-For-Children-And-Adolescents-Part-I-How-Medications-Are-Used-021.aspx
- Weinberg HA. Improved Functioning in Children Diagnosed with Reactive Attachment Disorder after SSRI Therapy. Journal of the Canadian Academy of Child and Adolescent Psychiatry. 2010;19(1):48-50. https://pmc.ncbi.nlm.nih.gov/articles/PMC2809447/
- Minnesota Statutes 260C.212, subdivision 1, Out-of-Home Placement Plan. https://www.revisor.mn.gov/statutes/cite/260C.212
- Talmon-Knuser F, Flores-Cantos L, Espuig A, Gonzalez-Sala F, Lacomba-Trejo L. Childhood Adversity and Reactive Attachment Disorder in Adolescents: A Systematic Review. Journal of Child and Adolescent Trauma. 2026;19(1):45-57. https://pmc.ncbi.nlm.nih.gov/articles/PMC13004762/
